{
  "description": null,
  "compose": {
    "include": [ {
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "concept": [ {
        "code": "1373458",
        "display": "canagliflozin"
      }, {
        "code": "1488564",
        "display": "dapagliflozin"
      }, {
        "code": "1545653",
        "display": "empagliflozin"
      }, {
        "code": "1992672",
        "display": "ertugliflozin"
      } ]
    } ]
  },
  "_filename": "ValueSet-2.16.840.1.113762.1.4.1178.43.json",
  "package_name": "us.nlm.vsac",
  "date": "2022-07-16T01:02:12-04:00",
  "meta": {
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ],
    "versionId": "5",
    "lastUpdated": "2022-07-16T01:02:12.000-04:00"
  },
  "publisher": "AHA Steward",
  "jurisdiction": [ {
    "coding": [ {
      "code": "US",
      "system": "urn:iso:std:iso:3166"
    } ]
  } ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for medications of sodium glucose co-transporter 2 (SGLT2) ingredients.),(Data Element Scope: This value set may use a model element related to Allergy/Intolerance.),(Inclusion Criteria: Includes concepts that represent an allergy or intolerance for prescribable sodium glucose co-transporter 2 (SGLT2) ingredients only.),(Exclusion Criteria: No exclusions.)",
  "name": "SGLT2Ingredients",
  "type": null,
  "experimental": "false",
  "resourceType": "ValueSet",
  "expansion": {
    "total": 4,
    "contains": [ {
      "code": "1373458",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "canagliflozin",
      "version": "11062023"
    }, {
      "code": "1488564",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "dapagliflozin",
      "version": "11062023"
    }, {
      "code": "1545653",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "empagliflozin",
      "version": "11062023"
    }, {
      "code": "1992672",
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "display": "ertugliflozin",
      "version": "11062023"
    } ],
    "timestamp": "2023-12-10T22:36:18-05:00",
    "identifier": "urn:uuid:899e45d1-e634-4b70-8ca2-7e3ba3738926"
  },
  "title": "SGLT2 Ingredients",
  "package_version": "0.17.0",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString": "AHA Author"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate": "2023-02-07"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2022-07-16"
  } ],
  "status": "active",
  "id": "7be7e19b-2d20-4355-ae8d-e6a5e0223560",
  "kind": null,
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.43",
  "identifier": [ {
    "value": "urn:oid:2.16.840.1.113762.1.4.1178.43",
    "system": "urn:ietf:rfc:3986"
  } ],
  "version": "20220716"
}